Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Gregory Nishimura

Surgery Hewlett, NY Medical Doctor

NPI 1881744795 CMS profile 221132

1420 Broadway, Hewlett, NY 11557

Open in the dashboard

General payments

$12,188

58 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Gregory Nishimura of Hewlett, NY is reported in the CMS Open Payments database as having received $12,188 across 58 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $346 5
2022 General $9,820 32
2021 General $1,198 7
2020 General $45 1
2019 General $779 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gregory Nishimura
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Gregory Nishimura were reported at $0. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Gregory Nishimura Surgery median Middle half National median
2019 $779 $253 $82–$1,521 $163
2020 $45 $131 $40–$706 $114
2021 $1,198 $168 $50–$904 $132
2022 $9,820 $224 $76–$1,218 $149
2023 $346 $253 $82–$1,255 $160
2024 $0 $279 $90–$1,381 $164
2025 $0 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Intuitive Surgical, Inc. $8,258 18 payments
  2. Medtronic, Inc. $977 7 payments
  3. Apollo Endosurgery US Inc $889 8 payments
  4. Covidien LP $495 7 payments
  5. Intra-Sana Laboratories $355 1 payment
  6. Teleflex LLC $271 3 payments
  7. Boston Scientific Corporation $188 1 payment
  8. Standard Bariatrics, Inc. $133 2 payments
  9. RedHill Biopharma Inc. $118 1 payment
  10. Avanos Medical $115 1 payment
  11. Other $390 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Education $7,753 4 payments
  2. Food and Beverage $3,787 52 payments
  3. Travel and Lodging $647 2 payments
Products named General payments · program years 2019–2023
  1. DAVINCI XI $7,750 3 payments
  2. Signia $899 6 payments
  3. OverStitch Endoscopic Suturing System $889 8 payments
  4. ORBERA Intragastric Balloon System $869 7 payments
  5. Da Vinci Surgical System $508 15 payments
  6. RELTONE 200 MG $355 1 payment
  7. RELTONE 400 MG $355 1 payment
  8. LigaSure $295 3 payments
  9. SPYGLASS $188 1 payment
  10. Titan SGS Standard Gastric Stapler $135 2 payments
  11. Other $1,180 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

58 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record